Tokyo Tape
Sign in
← Tohoku Chemical

Annual report

7446.TEDINET S100PTYB
Period2021-10-01 → 2022-09-30
Filed2022-12-21
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed

Amended by S100RSYI (2023-09-05).

Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥37.3bn2021-10-01 → 2022-09-30Cons.Net sales
Revenue¥36.2bn2020-10-01 → 2021-09-30Cons.Net sales
Revenue¥31.0bn2019-10-01 → 2020-09-30dCons.Net sales (5-year summary)
Revenue¥31.0bn2018-10-01 → 2019-09-30dCons.Net sales (5-year summary)
Revenue¥31.7bn2017-10-01 → 2018-09-30dCons.Net sales (5-year summary)
Operating income¥944m2021-10-01 → 2022-09-30Cons.Operating income
Operating income¥713m2020-10-01 → 2021-09-30Cons.Operating income
Ordinary income¥1.0bn2021-10-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥759m2020-10-01 → 2021-09-30Cons.Ordinary income
Ordinary income¥410m2019-10-01 → 2020-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥330m2018-10-01 → 2019-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥333m2017-10-01 → 2018-09-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥975m2021-10-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥748m2020-10-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥658m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥517m2020-10-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥378m2019-10-01 → 2020-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥221m2018-10-01 → 2019-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥306m2017-10-01 → 2018-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥681m2021-10-01 → 2022-09-30Cons.Profit loss
Net income¥538m2020-10-01 → 2021-09-30Cons.Profit loss
Total assets¥17.5bnat 2022-09-30Cons.Assets
Total assets¥16.1bnat 2021-09-30Cons.Assets
Total assets¥14.6bnat 2020-09-30dCons.Total assets (5-year summary)
Total assets¥14.8bnat 2019-09-30dCons.Total assets (5-year summary)
Total assets¥15.5bnat 2018-09-30dCons.Total assets (5-year summary)
Total liabilities¥10.8bnat 2022-09-30Cons.Liabilities
Total liabilities¥9.8bnat 2021-09-30Cons.Liabilities
Net assets / equity¥6.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥6.3bnat 2021-09-30Cons.Net assets
Net assets / equity¥5.7bnat 2020-09-30dCons.Net assets
Net assets / equity¥5.4bnat 2019-09-30dCons.Net assets (5-year summary)
Net assets / equity¥5.3bnat 2018-09-30dCons.Net assets (5-year summary)
Cash and deposits¥1.4bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥799mat 2021-09-30Cons.Cash and deposits
Cash & equivalents¥1.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥660mat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥730mat 2020-09-30dCons.Cash and cash equivalents
Cash & equivalents¥596mat 2019-09-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥1.5bnat 2018-09-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥886m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥322m2020-10-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥441m2019-10-01 → 2020-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥765m2018-10-01 → 2019-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥335m2017-10-01 → 2018-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥92m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥172m2020-10-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥205m2019-10-01 → 2020-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥143m2018-10-01 → 2019-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥122m2017-10-01 → 2018-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥186m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥221m2020-10-01 → 2021-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥511m2019-10-01 → 2020-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥15m2018-10-01 → 2019-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥209m2017-10-01 → 2018-09-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥728.762021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥564.912020-10-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥404.572019-10-01 → 2020-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥236.32018-10-01 → 2019-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥326.182017-10-01 → 2018-09-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥7,330.63at 2022-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥6,829.86at 2021-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥6,023.38at 2020-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥5,693.08at 2019-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥5,637.31at 2018-09-30dCons.Net assets per share (5-year summary)
Equity ratio37.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.6%at 2021-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.5%at 2020-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio36.2%at 2019-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio34.0%at 2018-09-30dCons.Equity to asset ratio (5-year summary)
ROE10.2%2021-10-01 → 2022-09-30Cons.Rate of return on equity (5-year summary)
ROE8.7%2020-10-01 → 2021-09-30Cons.Rate of return on equity (5-year summary)
ROE6.9%2019-10-01 → 2020-09-30dCons.Rate of return on equity (5-year summary)
ROE4.2%2018-10-01 → 2019-09-30dCons.Rate of return on equity (5-year summary)
ROE5.9%2017-10-01 → 2018-09-30dCons.Rate of return on equity (5-year summary)
Employees321at 2022-09-30Cons.Number of employees
Employees316at 2021-09-30Cons.Number of employees
Employees314at 2020-09-30dCons.Number of employees
Employees309at 2019-09-30dCons.Number of employees
Employees329at 2018-09-30dCons.Number of employees
Revenue¥28.4bn2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥27.8bn2020-10-01 → 2021-09-30StandaloneNet sales
Revenue¥24.4bn2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥24.3bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Revenue¥24.6bn2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Operating income¥792m2021-10-01 → 2022-09-30StandaloneOperating income
Operating income¥591m2020-10-01 → 2021-09-30StandaloneOperating income
Ordinary income¥846m2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥633m2020-10-01 → 2021-09-30StandaloneOrdinary income
Ordinary income¥380m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥318m2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥347m2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥817m2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥633m2020-10-01 → 2021-09-30StandaloneIncome before income taxes
Net income¥547m2021-10-01 → 2022-09-30StandaloneProfit loss
Net income¥424m2020-10-01 → 2021-09-30StandaloneProfit loss
Net income¥356m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income¥214m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Net income¥218m2017-10-01 → 2018-09-30dStandaloneNet income loss (5-year summary)
Total assets¥14.1bnat 2022-09-30StandaloneAssets
Total assets¥13.0bnat 2021-09-30StandaloneAssets
Total assets¥11.7bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥11.7bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total assets¥12.5bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥7.8bnat 2022-09-30StandaloneLiabilities
Total liabilities¥7.0bnat 2021-09-30StandaloneLiabilities
Net assets / equity¥6.3bnat 2022-09-30StandaloneNet assets
Net assets / equity¥6.0bnat 2021-09-30StandaloneNet assets
Net assets / equity¥5.5bnat 2020-09-30dStandaloneNet assets
Net assets / equity¥5.3bnat 2019-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥5.2bnat 2018-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥671mat 2021-09-30StandaloneCash and deposits
EPS (basic)¥606.072021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥463.892020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥380.412019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥228.092018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥232.822017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥1152021-10-01 → 2022-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥1052020-10-01 → 2021-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥902019-10-01 → 2020-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥902018-10-01 → 2019-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥902017-10-01 → 2018-09-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥6,987.67at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥6,615.32at 2021-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥5,917.64at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥5,610.97at 2019-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥5,564.01at 2018-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio44.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.4%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio47.4%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.9%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio41.6%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE8.9%2021-10-01 → 2022-09-30StandaloneRate of return on equity (5-year summary)
ROE7.3%2020-10-01 → 2021-09-30StandaloneRate of return on equity (5-year summary)
ROE6.6%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
ROE4.1%2018-10-01 → 2019-09-30dStandaloneRate of return on equity (5-year summary)
ROE4.3%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued960,000at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued960,000at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued960,000at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued960,000at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued960,000at 2018-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees236at 2022-09-30StandaloneNumber of employees
Employees230at 2021-09-30StandaloneNumber of employees
Employees228at 2020-09-30dStandaloneNumber of employees
Employees226at 2019-09-30dStandaloneNumber of employees
Employees232at 2018-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 33
SegmentItemPeriodValue
Otherother segmentsemployeesat 2022-09-306 pure
Otherother segmentsrevenue2021-10-01 → 2022-09-30¥384m
Otherother segmentsrevenue external2021-10-01 → 2022-09-30¥384m
Otherother segmentsrevenue external2021-10-01 → 2022-09-30¥384m
Foodreportable segmentemployeesat 2022-09-3015 pure
Foodreportable segmentrevenue2021-10-01 → 2022-09-30¥3.3bn
Foodreportable segmentrevenue external2021-10-01 → 2022-09-30¥3.3bn
Foodreportable segmentrevenue external2021-10-01 → 2022-09-30¥3.3bn
Pharmaceutical Productsreportable segmentemployeesat 2022-09-3077 pure
Pharmaceutical Productsreportable segmentrevenue2021-10-01 → 2022-09-30¥18.0bn
Pharmaceutical Productsreportable segmentrevenue external2021-10-01 → 2022-09-30¥18.0bn
Pharmaceutical Productsreportable segmentrevenue external2021-10-01 → 2022-09-30¥18.0bn
Reagent For Clinical Testreportable segmentemployeesat 2022-09-3069 pure
Reagent For Clinical Testreportable segmentrevenue2021-10-01 → 2022-09-30¥15.6bn
Reagent For Clinical Testreportable segmentrevenue external2021-10-01 → 2022-09-30¥15.6bn
Reagent For Clinical Testreportable segmentrevenue external2021-10-01 → 2022-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-10-01 → 2022-09-30¥37.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-10-01 → 2022-09-30¥37.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-10-01 → 2022-09-30¥37.3bn
Otherother segmentsrevenue2020-10-01 → 2021-09-30¥417m
Otherother segmentsrevenue external2020-10-01 → 2021-09-30¥417m
Foodreportable segmentrevenue2020-10-01 → 2021-09-30¥3.3bn
Foodreportable segmentrevenue external2020-10-01 → 2021-09-30¥3.3bn
Pharmaceutical Productsreportable segmentrevenue2020-10-01 → 2021-09-30¥17.8bn
Pharmaceutical Productsreportable segmentrevenue external2020-10-01 → 2021-09-30¥17.8bn
Reagent For Clinical Testreportable segmentrevenue2020-10-01 → 2021-09-30¥14.7bn
Reagent For Clinical Testreportable segmentrevenue external2020-10-01 → 2021-09-30¥14.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2020-10-01 → 2021-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-10-01 → 2021-09-30¥36.2bn
Otherother segmentsemployeesat 2022-09-302 pure
Foodreportable segmentemployeesat 2022-09-308 pure
Pharmaceutical Productsreportable segmentemployeesat 2022-09-3063 pure
Reagent For Clinical Testreportable segmentemployeesat 2022-09-3029 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,654
ItemContextValueUnit
Provision of general reserveCurrentYearDuration_NonConsolidatedMember－JPY
Dividends from surplusCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember-95762000JPY
Dividends from surplusCurrentYearDuration_NonConsolidatedMember-95762000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember546903000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember546903000JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember-35340000JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember-35340000JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember-35340000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-191381000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-191381000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember-191381000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember-35340000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember415800000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-191381000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-191381000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember224418000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-168907000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember5717249000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember578805000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember578805000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember6296054000JPY
Payroll and allowances sgaPrior1YearDuration_NonConsolidatedMember1135211000JPY
Payroll and allowances sgaCurrentYearDuration_NonConsolidatedMember1164077000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember57784000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember53612000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember30000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember30600000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember38253000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember37034000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration_NonConsolidatedMember-410000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration_NonConsolidatedMember342000JPY
Provision for directors retirement benefits sgaPrior1YearDuration_NonConsolidatedMember4956000JPY
Provision for directors retirement benefits sgaCurrentYearDuration_NonConsolidatedMember6348000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東北財務局長
Filing date cover pageFilingDateInstant2022-12-21
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第71期(自　2021年10月１日　至　2022年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)東北化学薬品株式会社
Company name in english cover pageFilingDateInstantTOHOKU　CHEMICAL　CO.,　LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　東 康之　
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)青森県弘前市大字神田一丁目３番地の１
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)0172(33)8131　(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)上席執行役員管理グループ長　磯辺　譲
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)青森県弘前市大字神田一丁目３番地の１
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)0172(33)8131　(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)上席執行役員管理グループ長　磯辺　譲
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE02810
Fund codeFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-09-30pass rounding
balance sheet identityconsolidated 2022-09-30pass
balance sheet identitynon_consolidated 2021-09-30pass
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-09-30pass
statement vs summary · net assetsconsolidated 2021-09-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2020-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-09-30pass
statement vs summary · revenueconsolidated 2020-10-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-09-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass